Main content area

Zinc Sulfate and/or Growth Hormone Administration for the Prevention of Radiation-Induced Dermatitis: a Placebo-Controlled Rat Model Study

Kandaz, Mustafa, Ertekin, Mustafa Vecdi, Karslıoğlu, İhsan, Erdoğan, Fazlı, Sezen, Orhan, Gepdiremen, Akçahan, Gündoğdu, Cemal
Biological trace element research 2017 v.179 no.1 pp. 110-116
animal models, atrophy, dermatitis, gamma radiation, hair follicles, irradiation, legs, radiation injury, rats, somatotropin, subcutaneous injection, zinc, zinc sulfate
Growth hormone (GH) and zinc (Zn) were evaluated for their potential to prevent radiation injury using a rat model of radiation-induced skin injury. Sprague–Dawley rats were divided into five groups: a control group not receiving Zn, GH, or irradiation: a radiation (RT) group receiving a single 30 Gy dose of gamma irradiation to the right hind legs; a radiation + GH group (RT + GH) receiving a single 30 Gy dose of gamma irradiation plus the subcutaneous administration of 0.01 IU kg d⁻¹ GH; a radiation + Zn group (RT + Zn) receiving a single 30 Gy dose plus 5 mg kg d⁻¹ Zn po; and a radiation + GH + Zn group (RT + GH + Zn) group receiving a single 30 Gy dose plus subcutaneous 0.01 IU kg d⁻¹ GH and 5 mg kg d⁻¹ Zn po. Acute skin reactions were assessed every 3 days by two radiation oncologists grouping. Light microscopic findings were assessed blindly by two pathologists. Groups receiving irradiation were associated with dermatitis as compared to the control group (P < 0.05). The severity of radiodermatitis in the RT + GH, RT + Zn, and RT + GH + Zn groups was significantly lower than that in the RT group (P < 0.05). Furthermore, radiodermatitis was observed earlier in the RT group than in the other treatment groups (P < 0.05). GH and Zn effectively prevented epidermal atrophy, dermal degeneration, and hair follicle atrophy. The highest level of protection against radiation dermatitis was observed in the combination group.